Delivery Order SPE2DB22D1041-SPE2DB24FUDR2

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 20 MG CAPSULE 100S. The order has a firm fixed price of $2,890.08 and a completion date of July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for providing a range of medical commodities to support military treatment...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,567.13 to provide VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of November 27, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 70 MG CAPSULE 100S. The contract has a firm fixed price, is not set aside, and has a ceiling value of $1,288.61. The ultimate completion date is May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a medication, with a ceiling value of $2,142.14 and a performance period ending on June 26, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 40 MG CAPSULE 100S. The contract has a ceiling value of $3,433.26 and runs through February 24, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4565192263 VYVANSE 60 MG CAPSULE 100S. The contract has a ceiling value of $3,030.68 and an ultimate completion date of July 19, 2024. The award is not set aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of VYVANSE 70 MG CAPSULE 100S. The contract has a ceiling value of $1,904.11 and a completion date of May 16, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and this award is associated with a larger Indefinite Delivery Contract (IDC) valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,407.59 firm fixed-price contract is for the delivery of VYVANSE 70 MG CAPSULE 100S, a prescription medication. The award is not associated with a set-aside program and has an ultimate completion date of May 22, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,873.63 firm fixed-price delivery order is for the supply of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of VYVANSE 40 MG CAPSULE 100S, a medication, at a ceiling value of $2,796.79. The contract is a firm fixed-price, delivery order type, with an ultimate completion date of July 18, 2024. This contract is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUDR2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 20 MG CAPSULE 100S. The award has a ceiling value of $1,673.36 and a completion date of September 10, 2024. The contract is a Firm Fixed Price type. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, for providing a wide range of pharmaceutical and medical supplies to support military treatment programs, veterans' hospitals, and other federal healthcare providers. This specific delivery order is not designated as a set-aside contract.

Generated 12/9/24, 2:00 PM